Benzinga

Benzinga

Benzinga

jueves, septiembre 10

Abbott Laboratories

ABTNYSE
Trade with Public
Trade with Public
$105.23
-0.29-0.27%
al cierre: Sep 9, 5:00 PM EST
$105.10
-0.13-0.12%
After hour: 4:31 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Abbott Laboratories Financials

Abbott Laboratories (ABT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.
Avi Kapoor

Why Is Intuitive Surgical Stock Sinking Friday?

ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow U.S. procedure growth.
Lekha Gupta

Nasdaq Tumbles 1.5% Amid Selloff In Chip Stocks: Investor Sentiment Weakens, Greed Index Moves To ‘Fear’ Zone

Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and Abbott Laboratories reported strong earnings.
Avi Kapoor

Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook

Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its full-year profit outlook. Read more.
Vandana Singh

PRO
Abbott Projects Full-Year 2026 Comparable Sales Growth Of 6.5% To 7.5%

Benzinga Newsdesk

PRO
Abbott Laboratories Sees Q3 Adj EPS $1.38-$1.46 vs $1.42 Est

Abbott Laboratories (NYSE:ABT) is looking for Q3 Adj EPS of $1.38-$1.46 vs $1.42 analyst estimate..
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved